BiotechTube
Home/LianBio/Debra Yu, M.D.
DY

Debra Yu, M.D.

Former Chief Executive Officer and Director

LianBio

Therapeutic Areas

OncologyCardiovascularOphthalmologyFibrotic Diseases

LianBio Pipeline

DrugIndicationPhase
MavacamtenObstructive Hypertrophic Cardiomyopathy (oHCM)Approved (China NMPA Review)
TP-03 (lotilaner)Demodex BlepharitisPhase 3
NBTXR3Locally Advanced Head and Neck Squamous Cell CarcinomaPhase 3
InfigratinibCholangiocarcinomaPhase 2
LYT-100 (deupirfenidone)Idiopathic Pulmonary Fibrosis (IPF)Phase 2
Tunnel ProgramUndisclosed Gastrointestinal TargetsPre-clinical

Leadership Team at LianBio

KP
Konstantin Poukalov
Executive Director and Interim Chief Executive Officer
YL
Yi Larson
Chief Financial Officer
JP
Jeff Poulton
Former Chief Financial Officer
YW
Yizhe Wang, Ph.D.
Chief Scientific Officer
SW
Sizhen Wang
General Manager, China
MH
Michael Humphries
Chief Business Officer
PK
Perry Karsen
Chairman of the Board of Directors
MM
Mark McDade
Director
AS
Alice Shaw, M.D., Ph.D.
Director
JB
James B. Tananbaum, M.D.
Director
View full LianBio profile